ARCHIVES

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Elderly Patients Fail To Receive New Cancer Therapy For CML

August 27, 2010

2015: “A Challenge For Our Generation,” AACR Says

July 18, 2003

In Brief: Michael Boyd Named New DTP Director; Saunders Retires; Michael Friedman New Chief Of CIB

October 7, 1983

Psychiatric Disorders Often Overlooked By Oncologists

September 28, 2007

Advances Found In Treatment Of Aerodigestive Cancers

May 25, 2001

In Brief: CDP Services Wins ASC Planning Contract; Jury Finds Sarin Guilty of Embezzlement

July 17, 1992